scholarly article | Q13442814 |
P819 | ADS bibcode | 2011PLoSO...629088R |
P356 | DOI | 10.1371/JOURNAL.PONE.0029088 |
P932 | PMC publication ID | 3237596 |
P698 | PubMed publication ID | 22194994 |
P5875 | ResearchGate publication ID | 51921109 |
P50 | author | Jacqueline Stockley | Q56697387 |
Prabhakar Rajan | Q60976609 | ||
Cedric Simillion | Q37368009 | ||
David J Elliott | Q38323411 | ||
Hing Y Leung | Q40453449 | ||
P2093 | author name string | Michael Q Zhang | |
Chaolin Zhang | |||
Caroline Dalgliesh | |||
Craig N Robson | |||
Gabriela Kalna | |||
Kelly Armstrong | |||
Luke Gaughan | |||
Phillippa J Carling | |||
Sushma N Grellscheid | |||
Thomas Buist | |||
P2860 | cites work | An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression | Q24313269 |
The RNA helicase p68 is a novel androgen receptor coactivator involved in splicing and is overexpressed in prostate cancer | Q24318348 | ||
The program of androgen-responsive genes in neoplastic prostate epithelium | Q24535711 | ||
The UCSC Genome Browser Database: update 2006 | Q24538714 | ||
AZU-1: a candidate breast tumor suppressor and biomarker for tumor progression | Q24548843 | ||
Determination of tag density required for digital transcriptome analysis: application to an androgen-sensitive prostate cancer model | Q24644698 | ||
Entrez Gene: gene-centered information at NCBI | Q24670011 | ||
Human PIRH2 enhances androgen receptor signaling through inhibition of histone deacetylase 1 and is overexpressed in prostate cancer | Q24670460 | ||
The human genome browser at UCSC | Q24672361 | ||
Statistical significance for genomewide studies | Q24681264 | ||
Transcriptional programs activated by exposure of human prostate cancer cells to androgen | Q24802648 | ||
FAST DB: a website resource for the study of the expression regulation of human gene products | Q24815689 | ||
Alternative isoform regulation in human tissue transcriptomes | Q27861118 | ||
Androgen-induced expression of endoplasmic reticulum (ER) stress response genes in prostate cancer cells | Q28217743 | ||
Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays | Q28235146 | ||
Molecular determinants of resistance to antiandrogen therapy | Q28236889 | ||
The tuberous sclerosis gene products hamartin and tuberin are multifunctional proteins with a wide spectrum of interacting partners | Q28269653 | ||
Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing | Q29547470 | ||
Cofactor of BRCA1 modulates androgen-dependent transcription and alternative splicing | Q30439381 | ||
Quantitative expression profile of androgen-regulated genes in prostate cancer cells and identification of prostate-specific genes | Q31892738 | ||
A new advance in alternative splicing databases: from catalogue to detailed analysis of regulation of expression and function of human alternative splicing variants. | Q33286653 | ||
Fisetin induces autophagic cell death through suppression of mTOR signaling pathway in prostate cancer cells | Q34042356 | ||
The transforming acidic coiled coil proteins interact with nuclear histone acetyltransferases | Q34295310 | ||
Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways | Q34562010 | ||
Exon arrays provide accurate assessments of gene expression | Q35906488 | ||
Tuberous sclerosis complex, implication from a rare genetic disease to common cancer treatment | Q37134137 | ||
The meaning of nonsense | Q37182097 | ||
Identification of PDE4D as a proliferation promoting factor in prostate cancer using a Sleeping Beauty transposon-based somatic mutagenesis screen | Q37262522 | ||
Induction of Kruppel-like factor 5 expression by androgens results in increased CXCR4-dependent migration of prostate cancer cells in vitro | Q37332423 | ||
Alternative splicing and biological heterogeneity in prostate cancer | Q37573399 | ||
The changing therapeutic landscape of castration-resistant prostate cancer | Q37913983 | ||
The RNA-binding and adaptor protein Sam68 modulates signal-dependent splicing and transcriptional activity of the androgen receptor | Q38293539 | ||
Identification and validation of novel androgen-regulated genes in prostate cancer | Q38341527 | ||
Estrogen regulation and physiopathologic significance of alternative promoters in breast cancer. | Q38344704 | ||
The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis | Q39538459 | ||
Microarray coupled to quantitative RT-PCR analysis of androgen-regulated genes in human LNCaP prostate cancer cells | Q39861422 | ||
New androgen receptor genomic targets show an interaction with the ETS1 transcription factor. | Q40089132 | ||
Differential regulation of clusterin and its isoforms by androgens in prostate cells | Q40200381 | ||
Androgens induce prostate cancer cell proliferation through mammalian target of rapamycin activation and post-transcriptional increases in cyclin D proteins | Q40248475 | ||
Identification of a novel Wee1 isoform | Q42816283 | ||
Coordinate regulation of transcription and splicing by steroid receptor coregulators | Q44177314 | ||
Targeting SRC family kinases inhibits growth and lymph node metastases of prostate cancer in an orthotopic nude mouse model | Q46616183 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | transcriptome | Q252857 |
P304 | page(s) | e29088 | |
P577 | publication date | 2011-12-14 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Identification of novel androgen-regulated pathways and mRNA isoforms through genome-wide exon-specific profiling of the LNCaP transcriptome | |
P478 | volume | 6 |
Q33855473 | A mutation in a splicing factor that causes retinitis pigmentosa has a transcriptome-wide effect on mRNA splicing. |
Q38365327 | A novel androgen-regulated isoform of the TSC2 tumour suppressor gene increases cell proliferation. |
Q38132132 | Alternative splicing programs in prostate cancer |
Q42880656 | Androgen receptor genomic regulation |
Q57135534 | Androgen-dependent alternative mRNA isoform expression in prostate cancer cells |
Q83227835 | Androgen-regulated transcription of drives alternative splicing patterns in prostate cancer |
Q35543453 | Androgen-regulation of the protein tyrosine phosphatase PTPRR activates ERK1/2 signalling in prostate cancer cells |
Q35063756 | Epidermal growth-factor-induced transcript isoform variation drives mammary cell migration |
Q53779715 | Expressional profiling of prostate cancer risk SNPs at 11q13.5 identifies DGAT2 as a new target gene. |
Q38757500 | Glycosylation is an Androgen-Regulated Process Essential for Prostate Cancer Cell Viability |
Q39341456 | Human PDE4D isoform composition is deregulated in primary prostate cancer and indicative for disease progression and development of distant metastases |
Q39984274 | Lyn tyrosine kinase regulates androgen receptor expression and activity in castrate-resistant prostate cancer |
Q39093621 | Next-generation sequencing of advanced prostate cancer treated with androgen-deprivation therapy |
Q43119456 | Novel 5' fusion partners of ETV1 and ETV4 in prostate cancer |
Q38909020 | Novel long non-coding RNAs are specific diagnostic and prognostic markers for prostate cancer |
Q39145696 | Nuclear ARVCF protein binds splicing factors and contributes to the regulation of alternative splicing |
Q39223617 | RNA splicing and splicing regulator changes in prostate cancer pathology |
Q40393450 | The PI3K regulatory subunit gene PIK3R1 is under direct control of androgens and repressed in prostate cancer cells. |
Q38259961 | The androgen receptor controls expression of the cancer-associated sTn antigen and cell adhesion through induction of ST6GalNAc1 in prostate cancer. |
Q33922376 | The role of mRNA splicing in prostate cancer |
Search more.